Entinostat for treatment of solid tumors and hematologic malignancies

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.10, 2011-10, pp. : 1455-1467

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

JAK2 inhibition for the treatment of hematologic and solid malignancies

By Harry Brian L Eckhardt S. Gail Jimeno Antonio

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 5, 2012-05 ,pp. : 637-655

Informa Healthcare

Access to resources Recommend Favorite

Immunotoxins in the Treatment of Hematologic Malignancies

Current Drug Targets, Vol. 7, Iss. 10, 2006-01 ,pp. : 1301-1311

Bentham Science Publishers

Access to resources Recommend Favorite

Recombinant Immunotoxins for the Treatment of Chemoresistant Hematologic Malignancies

Current Pharmaceutical Design, Vol. 15, Iss. 23, 2009-08 ,pp. : 2652-2664

Bentham Science Publishers

Access to resources Recommend Favorite

Update on immunomodulatory drugs (IMiDs) in hematologic and solid malignancies

By Schafer Peter H

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 10, 2012-07 ,pp. : 1541-1542

Informa Healthcare

Access to resources Recommend Favorite

Update on immunomodulatory drugs (IMiDs) in hematologic and solid malignancies

By Vallet Sonia Witzens-Harig Mathias Jaeger Dirk Podar Klaus

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 4, 2012-03 ,pp. : 473-494

Informa Healthcare

Access to resources Recommend Favorite